J. Næsdal

3.8k total citations
54 papers, 3.0k citations indexed

About

J. Næsdal is a scholar working on Gastroenterology, Surgery and Pharmacology. According to data from OpenAlex, J. Næsdal has authored 54 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Gastroenterology, 26 papers in Surgery and 24 papers in Pharmacology. Recurrent topics in J. Næsdal's work include Helicobacter pylori-related gastroenterology studies (26 papers), Inflammatory mediators and NSAID effects (24 papers) and Gastroesophageal reflux and treatments (17 papers). J. Næsdal is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (26 papers), Inflammatory mediators and NSAID effects (24 papers) and Gastroesophageal reflux and treatments (17 papers). J. Næsdal collaborates with scholars based in Sweden, United States and United Kingdom. J. Næsdal's co-authors include Emeran A. Mayer, Neville D. Yeomans, Robert E. Spiller, C J Hawkey, Roger Bolus, Lin Chang, Bruce D. Naliboff, A. Walan, Eugene Campbell and Alan C. Perkins and has published in prestigious journals such as The Lancet, Gastroenterology and Gut.

In The Last Decade

J. Næsdal

52 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. Næsdal Sweden	26	1.7k	1.3k	597	429	336	54	3.0k
Andrés Acosta United States	38	1.2k 0.7×	1.9k 1.5×	729 1.2×	1.5k 3.6×	130 0.4×	151	4.4k
George E. Dukes United States	28	1.6k 0.9×	1.0k 0.8×	129 0.2×	897 2.1×	52 0.2×	97	3.1k
G. Dotevall Sweden	24	1.5k 0.8×	1.2k 1.0×	124 0.2×	500 1.2×	74 0.2×	84	2.7k
Enrique Rey Spain	29	1.4k 0.8×	1.2k 1.0×	160 0.3×	299 0.7×	59 0.2×	141	2.6k
Jan S. Redfern United States	21	283 0.2×	618 0.5×	447 0.7×	237 0.6×	145 0.4×	55	1.9k
Erik Muls Belgium	27	377 0.2×	737 0.6×	287 0.5×	799 1.9×	301 0.9×	76	2.9k
David H. Lawson United Kingdom	28	231 0.1×	565 0.4×	855 1.4×	396 0.9×	464 1.4×	74	3.8k
Michelle I. Wilde New Zealand	26	173 0.1×	461 0.4×	347 0.6×	183 0.4×	162 0.5×	43	2.0k
Miguel A. Rubio Spain	37	197 0.1×	2.3k 1.8×	318 0.5×	1.4k 3.2×	410 1.2×	214	4.8k
Sanford H. Roth United States	26	166 0.1×	566 0.4×	1.2k 1.9×	400 0.9×	142 0.4×	58	2.4k

Countries citing papers authored by J. Næsdal

Since Specialization

Citations

This map shows the geographic impact of J. Næsdal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Næsdal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Næsdal more than expected).

Fields of papers citing papers by J. Næsdal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Næsdal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Næsdal. The network helps show where J. Næsdal may publish in the future.

Co-authorship network of co-authors of J. Næsdal

This figure shows the co-authorship network connecting the top 25 collaborators of J. Næsdal. A scholar is included among the top collaborators of J. Næsdal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Næsdal. J. Næsdal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bytzer, Peter, Stephen D. Pratt, Eric P. Elkin, J. Næsdal, & Elisabeth Sörstadius. (2012). Burden of Upper Gastrointestinal Symptoms in Patients Receiving Low-Dose Acetylsalicylic Acid for Cardiovascular Risk Management. American Journal of Cardiovascular Drugs. 13(1). 27–35. 7 indexed citations

Hawkey, Christopher J., et al.. (2009). Esomeprazole for the Management of Upper Gastrointestinal Symptoms in Patients Who Require NSAIDs. Clinical Drug Investigation. 29(10). 677–687. 7 indexed citations

Niazi, Mohammad, et al.. (2009). Evaluation of the pharmacokinetic interaction between esomeprazole (40 mg) and acetylsalicylic acid (325 mg) in healthy volunteers. International Journal of Clinical Pharmacology and Therapeutics. 47(9). 564–569. 20 indexed citations

Drossman, Douglas A., et al.. (2008). Randomized, Double-Blind, Placebo-Controlled Trial of the 5-HT_1AReceptor Antagonist AZD7371 Tartrate Monohydrate (Robalzotan Tartrate Monohydrate) in Patients With Irritable Bowel Syndrome. The American Journal of Gastroenterology. 103(10). 2562–2569. 22 indexed citations

Hawkey, Christopher J., Nicholas J. Talley, James M. Scheiman, et al.. (2007). Maintenance treatment with esomeprazole following initial relief of non-steroidal anti-inflammatory drug-associated upper gastrointestinal symptoms: the NASA2 and SPACE2 studies. Arthritis Research & Therapy. 9(1). R17–R17. 16 indexed citations

Næsdal, J. & Kurt Brown. (2006). NSAID-Associated Adverse Effects and Acid Control Aids to Prevent Them. Drug Safety. 29(2). 119–132. 92 indexed citations

Yeomans, Neville D., et al.. (2006). Is ranitidine therapy sufficient for healing peptic ulcers associated with non-steroidal anti-inflammatory drug use?. International Journal of Clinical Practice. 60(11). 1401–1407. 18 indexed citations

Scheiman, James M., Neville D. Yeomans, Nicholas J. Talley, et al.. (2006). Prevention of Ulcers by Esomeprazole in At-Risk Patients Using Non-Selective NSAIDs and COX-2 Inhibitors. The American Journal of Gastroenterology. 101(4). 701–710. 212 indexed citations

Dunlop, Simon P., John M. Hebden, Eugene Campbell, et al.. (2006). Abnormal Intestinal Permeability in Subgroups of Diarrhea-Predominant Irritable Bowel Syndromes. The American Journal of Gastroenterology. 101(6). 1288–1294. 378 indexed citations

10.

Hawkey, C J, Nicholas J. Talley, Neville D. Yeomans, et al.. (2005). Improvements with Esomeprazole in Patients with Upper Gastrointestinal Symptoms Taking Non-Steroidal Antiinflammatory Drugs, Including Selective COX-2 Inhibitors. The American Journal of Gastroenterology. 100(5). 1028–1036. 75 indexed citations

11.

Yeomans, Neville D., Angel I. Lanas, Nicholas J. Talley, et al.. (2005). Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirin. Alimentary Pharmacology & Therapeutics. 22(9). 795–801. 203 indexed citations

12.

Longstreth, George F., Roger Bolus, Bruce D. Naliboff, et al.. (2005). Impact of irritable bowel syndrome on patients?? lives: development and psychometric documentation of a disease-specific measure for use in clinical trials. European Journal of Gastroenterology & Hepatology. 17(4). 411–420. 50 indexed citations

13.

Labus, Jennifer S., Roger Bolus, Lin Chang, et al.. (2004). The Visceral Sensitivity Index: development and validation of a gastrointestinal symptom‐specific anxiety scale. Alimentary Pharmacology & Therapeutics. 20(1). 89–97. 366 indexed citations

14.

Långström, Göran, et al.. (2001). Management of gastroduodenal ulcers and gastrointestinal symptoms associated with nonsteroidal anti-inflammatory drug therapy: A summary of four comparative trials with omeprazole, ranitidine, misoprostol, and placebo. Current Therapeutic Research. 62(12). 835–850. 4 indexed citations

15.

Dinan, Timothy G., Lucinda V. Scott, Jogin H. Thakore, J. Næsdal, & P. W. N. Keeling. (2001). Impact of cortisol on buspirone stimulated prolactin release: a double-blind placebo-controlled study. Psychoneuroendocrinology. 26(7). 751–756. 14 indexed citations

16.

Bredberg, Eva, et al.. (1998). Lack of drug-drug interaction between three different non-steroidal anti-inflammatory drugs and omeprazole. European Journal of Clinical Pharmacology. 54(5). 399–404. 25 indexed citations

17.

Bardhan, Karna Dev, J. Næsdal, G. Bianchi Porro, et al.. (1991). Treatment of refractory peptic ulcer with omeprazole or continued H2 receptor antagonists: a controlled clinical trial.. Gut. 32(4). 435–438. 32 indexed citations

18.

Laursen, L., K. Lauritsen, J. Næsdal, J Rask-Madsen, & Klaus Bukhave. (1990). Selective 5-lipoxygenase inhibition in ulcerative colitis. The Lancet. 335(8691). 683–685. 101 indexed citations

19.

Næsdal, J., et al.. (1990). Intravenous omeprazole: effect of a loading dose on 24‐h intragastric pH. Alimentary Pharmacology & Therapeutics. 4(1). 65–72. 39 indexed citations

20.

Danielsson, Åke, G Hellers, E Lyrenäs, et al.. (1987). A Controlled Randomized Trial of Budesonide versus Prednisolone Retention Enemas in Active Distal Ulcerative Colitis. Scandinavian Journal of Gastroenterology. 22(8). 987–992. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact